Neutrophil migration into the airspaces of the lung is thought to contribute to the alveolar damage and subsequent fibrosis in idiopathic pulmonary fibrosis (IPF 
Introduction
Idiopathic pulmonary fibrosis (IPF)' is a chronic, usually fatal interstitial lung disease characterized by injury of alveolar Dr. Carre's current address is Service de Pneumologie et Allergologie, 1 . Abbreviations used in this paper: BALF, bronchoalveolar lavage fluid; CRP, clinical-radiographic-physiologic (score); CTD, connective tissue disease; IPF, idiopathic pulmonary fibrosis; RT-PCR, reverse transcription-polymerase chain reaction.
parenchymal cells and by progressive fibrosis of the alveolar walls and interstitium (1, 2) . The pathogenesis of IPF likely involves the chronic accummulation of inflammatory and immune effector cells in the lower respiratory tract. Studies ofthe bronchoalveolar lavage fluid (BALF) from patients with IPF demonstrate a severalfold increase in the total cell number characterized by increases in the number of macrophages and neutrophils (3) (4) (5) (6) (7) (8) . However, the processes controlling the influx and efflux ofthese inflammatory cells in the alveolar space are not well understood.
It has been hypothesized that sustained neutrophil accumulation in the alveolar space, persistent neutrophil-mediated injury, and destruction of alveolar architecture are the major factors that culminate in abnormal lung repair and interstitial fibrosis (9) (10) (11) . The processes that sustain neutrophil influx into the alveolar space are unclear but appear to be mediated in part by neutrophil chemotactic factors released by macrophages (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Macrophages from patients with IPF spontaneously release a chemotactic factor for neutrophils (11) . This activity has been discriminated into a 400-600-D lipid-containing compound (1 1) , and a 5-10-kD protein (14, 15) . On the basis of similar biological activities and physicochemical properties, it has been suggested (16) that this latter protein may be interleukin 8 (IL-8), a recently purified (17), sequenced (18) , and cloned ( 19) monocyte-derived neutrophil chemotactic and granule-releasing factor of molecular mass 8,400 D (16, 20) .
While in vitro stimulation of human alveolar macrophages with tumor necrosis factor-a (TNFa), IL-I fl, or lipopolysaccharide (LPS) has been shown to induce the expression (21, 22) and secretion (23) 
Quantitation ofclinical impairment
Before the BAL, a history, physical examination, chest radiograph, and physiologic evaluation were performed in all patients. The physiologic evaluation included spirometry, measurement of lung mechanics, diffusing capacity for carbon monoxide, and measurement ofarterial blood gases at rest and during exercise. These procedures were performed as described elsewhere (24) . Clinical impairment was quantitated by means of a clinical-radiographic-physiologic (CRP) score (24) . The CRP score is derived from the assessment of eight variables: level ofactivity required to precipitate dyspnea; chest roentgenogram; forced vital capacity; forced expired volume in 1 s; thoracic gas volume of functional residual capacity; diffusing lung capacity for carbon monoxide corrected for alveolar volume; resting alveolar arterial oxygen pressure difference; and exercise-induced reduction in oxygen saturation indexed to the fraction of predicted maximal oxygen consumption achieved during exercise. In this scoring system, the higher the CRP score, the more severe the degree of impairment.
BAL BAL was performed in all patients awake in an outpatient setting by previously reported methods (5) . Sterile normal saline at room temperature was instilled through the bronchoscope in 60-ml aliquots to a total of 240 ml, with harvest ofthe fluid by immediate gentle hand suction applied to each instilling syringe. Differential counts on 400 cells were performed on Wright-Giemsa-stained cytocentrifuge preparations made from the pooled lavage fluid before centrifugation and resuspension. The cytocentrifuge preparations were made using a Cytospin-2 (Shandon Southern Instruments, Sewickly, PA), centrifuged at 400 g (2,000 rpm) for 15-20 s (Table I ). The pooled lavage fluid was centrifuged at 800 gfor 10 min, and the cell pellet was resuspended in serum-free RPMI 1640 culture medium without serum or antibiotics. Viability of the BAL cells was determined by trypan blue dye exclusion. Alveolar macrophages were purified by adherence to 100-mm diam plastic tissue culture dishes in serum-free RPMI 1640 at 37°C in an humidified atmosphere containing 5% CO2. After 15 min of incubation the nonadherent cells were removed and the layer of adherent cells was washed twice with 10 ml ofice-cold sterile PBS. These conditions were selected to minimize the induction of IL-8 gene expression, which has been reported to be induced in monocytes incubated in serum containing medium for > 30 min (25) . The purity of the macrophages was always greater than 98%. Isolation oftotal cellular RNA Total cellular RNA was extracted by lysis with 4 M guanidine isothiocyanate, and purified by centrifugation through 5.7 M cesium chloride at 100,000 g for 18 h (26). The RNA pellet was rinsed in 70% ethanol, resuspended in 300 ,ul of RNase-free water, ethanol-precipitated, dried, resuspended in 50 M1 of RNAse-free water, and quantified by absorbance measure- Preparation ofoligonucleotide primers Oligonucleotide primers were constructed from the published cDNA sequences of IL-8 and fl-actin cDNA (19, 28) . The primers were selected to: (1) span an intron-exon boundary in order to distinguish between amplification of mRNA and any contaminating genomic DNA (29, 30) , and (2) Verification ofPCR products as predicted segments ofspliced IL-8 and f-actin mRNAs. To verify that the amplification products derived from the IL-8 and #l-actin primers were authentic, we (1) determined the sizes of the amplified products and (2) prepared Southern blots ofthe amplified DNAs which we then probed with end-labeled oligonucleotides composed of sequences that were internal to the primers. The RNA was isolated from macrophages derived from an individual with IPF.
As can be seen in Fig. 1, A and B (lane 1) the amplification products of both IL-8 and fl-actin were identical to the predicted sizes for the mRNA template of255 and 314 bp, respectively. Bands of higher molecular weight were not detected indicating that genomic DNA was not being amplified. Fig. 1 (34, 35) . We have taken three approaches to ensure that the measurements taken in this study were during the exponential phase. First, we have varied the number of cycles of amplification to determine the points at which amplification is within the exponential phase. cDNAs were amplified from two normal subjects and two patients with IPF. As illustrated in Fig. 2 cycles, while the plateau of amplification was reached at 34 cycles.
Second, the efficiency of amplification is known to be constant for a given set of primers (34) , and thus the number of cycles after which the amplification ceases to be exponential is dependent on the abundance of starting cDNA. To verify that the amplification remained in the exponential phase under varying conditions of input cDNA, we amplified the IL-8 cDNA derived from each RNA sample at 28, 31, and 34 cycles thereby allowing us to verify that the efficiency of the amplification process was similar in the different groups studied. A representative sample of two healthy individuals and two patients with IPF is shown in Fig. 3 . It will be seen that the amplification of the IL-8 cDNA remained in the exponential phase for the two different patient groups.
Third, we also determined the relationship between input cDNA and the amount of amplified 32P-labeled product. Increasing amounts of input RNA Input RNA (ng) Figure 4 . Quantitative analysis of the IL-8 mRNA level. A cDNA mixture from one individual was serially diluted, i.e., 30, 24, 18, 12, or 6 ng of RNA equivalent from a same individual were subjected to 31 cycles of amplification. The figure shows a linear relationship between the input quantity of cDNA and the radioactivity of the corresponding amplified bands. did not reach a plateau at 20 and 23 cycles and that the efficiency was similar in the four groups (data not shown). As shown in Fig. 5 (Fig. 6 B) . The concentration of IL-8 in BALF in individuals with IPF-CTD was 32.7±7.4 and was not significantly different from healthy controls (P = 0.447) of from patients with IPF (P = 0.121).
Correlation of IL-8/1-actin ratio levels and disease severity.
We have investigated possible relationships between the IL-8/ f3-actin ratio and several biological and clinical parameters.
These parameters included number of white cells, macrophages, lymphocytes, neutrophils, or eosinophils in the lavage; age; smoking status, duration of illness, lung function parameters (total lung capacity, forced vital capacity, carbon monoxide diffusion capacity/alveolar ventilation, resting arterial oxygen pressure [Pao2]); the CRP score, an index ofdisease severity. A linear regression model was fitted to each of the quantitative variables individually.
Three variables were found to have a significant correlation with the IL-8/fi-actin ratio. As can be seen in Fig. 7 A, the number of neutrophils/ml of BAL fluid increased as the IL-8/ fi-actin levels increased (r2 = 0.63; P < 0.0001). The Pao2 (Fig.  7 B) decreased as the IL-8/(l-actin ratio increased (r2 = 0.313, P = 0.005), suggesting that the higher the IL-8/f-actin levels, the more severe the pulmonary dysfunction. The composite CRP score, a measure ofthe degree ofclinical impairment, was consistent with this trend. That is (Fig. 7 C) In this study, we developed a quantitative assay for IL-8 mRNA to enable us to examine the expression ofthis cytokine by alveolar macrophages immediately after sampling from the lung. This approach was adopted to provide information about one ofthe major cell types implicated in producing IL-8, without activating the cell in vitro. Hence the data obtained in this study would closely reflect the level ofIL-8 expression by alveolar macrophages in vivo. IL-8 mRNA expression was quantified by reverse transcription combined with amplification by the PCR. Such an approach has been shown to be a useful method for detecting small amounts of transcripts when applied to the quantification of RNAs from small numbers of cells or to characterize low abundant transcripts (31, 40, 41) . We demonstrate that the IL-8 gene is expressed in increased amounts by alveolar macrophages from patients with IPF, with or without an associated connective tissue disease, compared to those from normal individuals. Importantly (11) (12) (13) . A specific factor for neutrophil recruitment and retention in the lung has not been identified.
Several lines ofevidence support a role for the neutrophil in mediating the parenchymal injury found in patients with IPF (9, 10, (42) (43) (44) . The number of neutrophils in BALF and lung tissue from patients with IPF is increased and these neutrophils are capable of injuring lung cells and degrading interstitial matrix components by secreting proteases and oxidants, many of which are found in the BALF of patients with IPF. The data in this study therefore are important since they delineate further a mechanism by which neutrophils may be attracted to the lungs of patients with IPF: alveolar macrophages of patients with lavage neutrophilia exhibit an overexpression of the IL-8 gene.
In the present study, the IL-8 gene expression by alveolar macrophages from the IPF and IPF-CTD patients studied appears to be specifically related to (45, 46) . Alternatively, it has been shown that particulates present in cigarette smoke can stimulate alveolar macrophages in vitro and in vivo to exhibit a neutrophil chemotactic activity (47) . However, in the present study there was no difference in the extent of IL-8 expression between normal non-smokers and normal smokers. Furthermore, most of our patients were nonsmokers or ex-smokers. Consequently, the overexpression of IL-8 by alveolar macrophages in this study cannot be attributed to the presence of cigarette smoke in the respiratory tract.
In conclusion, we have shown that the IL-8 gene is overexpressed by alveolar macrophages from patients with ILD. As the principal resident cell in the lung, the alveolar macrophage plays a central role in host defense and injury. The generation of IL-8 by these cells provides a mechanism for the initiation and amplification of inflammation in the lung. The mechanism(s) by which alveolar macrophages are activated to express the IL-8 gene is unknown. A recent study suggested that neutrophil accumulation and activation in the lungs after connective tissue injury is mediated, at least in part, by factors released from alveolar macrophages (48) . Indeed, when stimulated in vitro by collagen peptides, macrophages released a neutrophil chemotactic factor whose physicochemical characteristics resembled those of IL-8 (48) . Since collagen injury is a usual feature in lung fibrosis, it is possible that in this situation, fragments from collagen breakdown are responsible for the activation of the expression of the IL-8 gene by alveolar macrophages. Although an increase in the synthesis and release of IL-8 in the BAL of patients with ILD remains to be determined, we believe that the quantification of the mRNA is a good basis for hypothesizing that IL-8 production by alveolar macrophages may be an important mechanism by which neutrophils are attracted to the lungs in pulmonary fibrosis. Indeed, in vitro studies have shown that IL-8 is regulated at the transcriptional level in alveolar macrophages and that induction of IL-8 expression is followed by synthesis and release of the protein (22) . Whether manipulations of IL-8 production at the gene level or antagonism ofthe actions ofIL-8 at the level of the neutrophil receptor could alter the influx of neutrophils into the lung and subsequently the fibrotic process remains to be established.
